Miransertib
Miransertib Uses, Dosage, Side Effects, Food Interaction and all others data.
Miransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).
Trade Name | Miransertib |
Generic | Miransertib |
Miransertib Other Names | Miransertib |
Type | |
Formula | C27H24N6 |
Weight | Average: 432.531 Monoisotopic: 432.206244797 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Miransertib